EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Acetaminophen use in pregnancy and autism: separating controversy from scientific evidence

Soon Cheol Hong, Jung Yeol Han, Sae Kyung Choi

Obstetrics & Gynecology Science · 15.07.2026 · 69 (4) · 249-253

DOI: 10.5468/ogs.26022 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Obstetrics & Gynecology Science, erschienen am 15.07.2026. Verfasst von Soon Cheol Hong und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Korea University College of Medicine, Seoul, Korea. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acetaminophen (paracetamol) has long been recommended as the preferred first-line analgesic and antipyretic in pregnancy, supported by decades of clinical experience, and has a more favorable safety profile than nonsteroidal anti-inflammatory drugs or opioids. Recently, however, political statements and media coverage linking maternal tylenol use to autism risk have amplified public concern and created uncertainty in clinical practice. This narrative review summarizes the current epidemiological evidence and positions of major professional societies and regulatory agencies on prenatal acetaminophen exposure and neurodevelopmental outcomes. A large Swedish nationwide cohort with a siblingcontrol analysis found no significant association between acetaminophen use during pregnancy and children’s risk of autism spectrum disorder, attentiondeficit/hyperactivity disorder, or intellectual disability, suggesting that the previously reported modest risk elevations largely reflect confounding and methodological limitations. Similar null findings from other high-quality cohort and siblingcomparison studies indicate no causal relationship between therapeutic prenatal acetaminophen use and major neurodevelopmental disorders. Consistent with these data, organizations such as the World Health Organization, American College of Obstetricians and Gynecologists, and national regulators continue to endorse short-term guideline-concordant acetaminophen use as appropriate in pregnancy. In routine obstetric care, emphasis should be placed on maternal safety, fetal well-being, and evidence-based counseling rather than non-evidencebased concerns, with acetaminophen used at the lowest effective dose for the shortest necessary duration unless future high-quality data indicate otherwise.

Schlagwörter

Stichwörter der Autor:innen

AcetaminophenAttention deficit disorder with hyperactivityAutism spectrum disorderCohort studiesPregnancy

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Korea University College of Medicine, Seoul, Korea.
  • Department of Obstetrics and Gynecology, Inje University Ilsan Paik Hospital, Goyang, Korea.
  • Department of Obstetrics and Gynecology, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea. obgysk@catholic.ac.kr.

Zitieren

APA

Hong, S. C., Han, J. Y., & Choi, S. K. (2026). Acetaminophen use in pregnancy and autism: separating controversy from scientific evidence. Obstetrics & Gynecology Science, 69(4), 249-253. https://doi.org/10.5468/ogs.26022

Vancouver

Hong SC, Han JY, Choi SK. Acetaminophen use in pregnancy and autism: separating controversy from scientific evidence. Obstetrics & Gynecology Science. 2026;69(4):249-253. doi:10.5468/ogs.26022

BibTeX
@article{Hong2026,
  author = {Hong, Soon Cheol and Han, Jung Yeol and Choi, Sae Kyung},
  title = {Acetaminophen use in pregnancy and autism: separating controversy from scientific evidence},
  journal = {Obstetrics & Gynecology Science},
  year = {2026},
  volume = {69},
  number = {4},
  pages = {249--253},
  doi = {10.5468/ogs.26022}
}
Kostenlos starten →